Bruker Operating Margin 2012-2026 | BRKR
Current and historical operating margin for Bruker (BRKR) over the last 10 years. The current operating profit margin for Bruker as of March 31, 2026 is 8.46%.
| Bruker Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2026-03-31 | $3.46B | $0.05B | 1.33% |
| 2025-12-31 | $3.44B | $0.07B | 1.98% |
| 2025-09-30 | $3.44B | $0.06B | 1.86% |
| 2025-06-30 | $3.44B | $0.18B | 5.35% |
| 2025-03-31 | $3.45B | $0.22B | 6.38% |
| 2024-12-31 | $3.37B | $0.25B | 7.51% |
| 2024-09-30 | $3.24B | $0.29B | 8.79% |
| 2024-06-30 | $3.12B | $0.34B | 10.93% |
| 2024-03-31 | $3.00B | $0.38B | 12.63% |
| 2023-12-31 | $2.96B | $0.44B | 14.74% |
| 2023-09-30 | $2.82B | $0.46B | 16.47% |
| 2023-06-30 | $2.71B | $0.47B | 17.35% |
| 2023-03-31 | $2.62B | $0.46B | 17.52% |
| 2022-12-31 | $2.53B | $0.43B | 17.11% |
| 2022-09-30 | $2.51B | $0.43B | 17.05% |
| 2022-06-30 | $2.48B | $0.41B | 16.53% |
| 2022-03-31 | $2.46B | $0.42B | 17.13% |
| 2021-12-31 | $2.42B | $0.41B | 17.08% |
| 2021-09-30 | $2.36B | $0.40B | 16.97% |
| 2021-06-30 | $2.27B | $0.37B | 16.29% |
| 2021-03-31 | $2.12B | $0.32B | 15.15% |
| 2020-12-31 | $1.99B | $0.25B | 12.47% |
| 2020-09-30 | $1.96B | $0.25B | 12.91% |
| 2020-06-30 | $1.97B | $0.26B | 13.20% |
| 2020-03-31 | $2.04B | $0.28B | 13.56% |
| 2019-12-31 | $2.07B | $0.30B | 14.58% |
| 2019-09-30 | $2.03B | $0.29B | 14.31% |
| 2019-06-30 | $1.97B | $0.27B | 13.74% |
| 2019-03-31 | $1.93B | $0.27B | 13.81% |
| 2018-12-31 | $1.90B | $0.26B | 13.81% |
| 2018-09-30 | $1.87B | $0.25B | 13.39% |
| 2018-06-30 | $1.84B | $0.23B | 12.64% |
| 2018-03-31 | $1.81B | $0.22B | 12.07% |
| 2017-12-31 | $1.77B | $0.22B | 12.39% |
| 2017-09-30 | $1.71B | $0.21B | 12.08% |
| 2017-06-30 | $1.66B | $0.20B | 12.08% |
| 2017-03-31 | $1.62B | $0.19B | 11.47% |
| 2016-12-31 | $1.61B | $0.18B | 11.30% |
| 2016-09-30 | $1.62B | $0.17B | 10.56% |
| 2016-06-30 | $1.62B | $0.15B | 9.44% |
| 2016-03-31 | $1.65B | $0.17B | 10.03% |
| 2015-12-31 | $1.62B | $0.15B | 8.99% |
| 2015-09-30 | $1.65B | $0.12B | 7.26% |
| 2015-06-30 | $1.68B | $0.10B | 5.78% |
| 2015-03-31 | $1.74B | $0.10B | 5.75% |
| 2014-12-31 | $1.81B | $0.11B | 5.86% |
| 2014-09-30 | $1.85B | $0.12B | 6.58% |
| 2014-06-30 | $1.87B | $0.15B | 7.96% |
| 2014-03-31 | $1.87B | $0.16B | 8.45% |
| 2013-12-31 | $1.84B | $0.15B | 8.10% |
| 2013-09-30 | $1.80B | $0.13B | 7.04% |
| 2013-06-30 | $1.81B | $0.16B | 8.55% |
| 2013-03-31 | $1.78B | $0.13B | 7.48% |
| 2012-12-31 | $1.79B | $0.16B | 8.65% |
| 2012-09-30 | $1.75B | $0.17B | 9.71% |
| 2012-06-30 | $1.72B | $0.15B | 8.60% |
| 2012-03-31 | $1.70B | $0.17B | 9.71% |
| 2011-12-31 | $1.65B | $0.16B | 9.51% |
| 2011-09-30 | $1.59B | $0.16B | 9.74% |
| 2011-06-30 | $1.48B | $0.16B | 10.51% |
| 2011-03-31 | $1.38B | $0.16B | 11.20% |
| 2010-12-31 | $1.31B | $0.16B | 11.95% |
| 2010-09-30 | $1.26B | $0.18B | 14.34% |
| 2010-06-30 | $1.21B | $0.17B | 13.80% |
| 2010-03-31 | $1.16B | $0.15B | 12.82% |
| 2009-12-31 | $1.12B | $0.14B | 12.20% |
| 2009-09-30 | $1.06B | $0.11B | 10.24% |
| 2009-06-30 | $1.04B | $0.10B | 9.41% |
| 2009-03-31 | $1.10B | $0.11B | 9.64% |
| 2008-12-31 | $1.11B | $0.11B | 9.76% |
| 2008-09-30 | $1.14B | $0.13B | 10.99% |
| 2008-06-30 | $1.14B | $0.14B | 12.31% |
| 2008-03-31 | $1.06B | $0.13B | 12.61% |
| 2007-12-31 | $1.03B | $0.14B | 13.36% |
| 2007-09-30 | $1.24B | $0.16B | 13.24% |
| 2007-06-30 | $1.10B | $0.14B | 12.79% |
| 2007-03-31 | $0.96B | $0.12B | 12.66% |
| 2006-12-31 | $0.85B | $0.11B | 12.57% |
| 2006-09-30 | $0.44B | $0.03B | 6.59% |
| 2006-06-30 | $0.42B | $0.03B | 6.41% |
| 2006-03-31 | $0.39B | $0.03B | 6.38% |
| 2005-12-31 | $0.37B | $0.02B | 6.18% |
| 2005-09-30 | $0.39B | $0.02B | 4.87% |
| 2005-06-30 | $0.37B | $0.01B | 3.78% |
| 2005-03-31 | $0.36B | $0.01B | 2.20% |
| 2004-12-31 | $0.36B | $0.01B | 1.69% |
| 2004-09-30 | $0.27B | $0.00B | -1.47% |
| 2004-06-30 | $0.27B | $-0.01B | -3.72% |
| 2004-03-31 | $0.27B | $-0.01B | -3.01% |
| 2003-12-31 | $0.26B | $-0.01B | -3.83% |
| 2003-09-30 | $0.30B | $-0.01B | -2.36% |
| 2003-06-30 | $0.29B | 0 | 0.00% |
| 2003-03-31 | $0.26B | $0.00B | 1.16% |
| 2002-12-31 | $0.22B | $0.01B | 2.26% |
| 2002-09-30 | $0.22B | $0.00B | 0.46% |
| 2002-06-30 | $0.19B | $0.00B | 0.54% |
| 2002-03-31 | $0.18B | $0.00B | 1.12% |
| 2001-12-31 | $0.18B | $0.00B | 1.14% |
| 2001-09-30 | $0.09B | $0.00B | 3.33% |
| 2001-06-30 | $0.09B | $0.00B | 3.37% |
| 2001-03-31 | $0.09B | $0.00B | 2.35% |
| 2000-12-31 | $0.08B | $0.00B | 1.28% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |